Association between national action and trends in antibiotic resistance: an analysis of 73 countries from 2000 to 2023.

PLOS global public health Pub Date : 2025-04-30 eCollection Date: 2025-01-01 DOI:10.1371/journal.pgph.0004127
Peter Søgaard Jørgensen, Luong Nguyen Thanh, Ege Pehlivanoğlu, Franziska Klein, Didier Wernli, Dusan Jasovsky, Athena Aktipis, Robert R Dunn, Yrjö Gröhn, Guillaume Lhermie, H Morgan Scott, Eili Y Klein
{"title":"Association between national action and trends in antibiotic resistance: an analysis of 73 countries from 2000 to 2023.","authors":"Peter Søgaard Jørgensen, Luong Nguyen Thanh, Ege Pehlivanoğlu, Franziska Klein, Didier Wernli, Dusan Jasovsky, Athena Aktipis, Robert R Dunn, Yrjö Gröhn, Guillaume Lhermie, H Morgan Scott, Eili Y Klein","doi":"10.1371/journal.pgph.0004127","DOIUrl":null,"url":null,"abstract":"<p><p>The world's governments have agreed on actions to address the challenge of antibiotic resistance. This raises the question of what level of national action is associated with improved outcomes, including both slower growth and lower levels of antibiotic resistance. Answering this question is challenged by variation in data availability and quality as well as disruptive events such as the COVID-19 pandemic. We investigate the association between level of national action and temporal trends in multiple indicators related to health system capacity, antibiotic use (ABU), absolute rates of resistance (ABR) and a Drug Resistance Index (DRI). Using the Global Database for Tracking Antimicrobial Resistance (TrACSS) to construct an index of national action, we apply cross-sectional regression across 73 countries to estimate the association between the level of action in 2016 and trends in national indicators (2000-2016). We find that national action is consistently associated with improved linear or categorical trends in all groups of indicators. Reductions are associated with a relatively high action index (range 0-4) for ABU (median 2.8, 25-75% quartile 2.6-3.3), ABR (3.0, 2.4-3.4), and DRI (3.5, 3.1-3.6). These associations are robust to the inclusion of other contextual factors related to socio-economic conditions, human population density, animal production and climate. Since 2016, a majority of both Low- and Middle-Income Countries (LMICs) and High-Income Countries (HICs) report increased action on repeated questions, while one third of countries report reduced action. The main limitations in interpretation are heterogeneity in data availability and in when actions have been implemented. Our findings highlight the importance of national action to address the domestic situation related to antibiotic resistance and indicate the value of both incremental changes in reducing adversity of outcomes and the need for high levels of action in delivering reduced levels of resistance.</p>","PeriodicalId":74466,"journal":{"name":"PLOS global public health","volume":"5 4","pages":"e0004127"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043137/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLOS global public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1371/journal.pgph.0004127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The world's governments have agreed on actions to address the challenge of antibiotic resistance. This raises the question of what level of national action is associated with improved outcomes, including both slower growth and lower levels of antibiotic resistance. Answering this question is challenged by variation in data availability and quality as well as disruptive events such as the COVID-19 pandemic. We investigate the association between level of national action and temporal trends in multiple indicators related to health system capacity, antibiotic use (ABU), absolute rates of resistance (ABR) and a Drug Resistance Index (DRI). Using the Global Database for Tracking Antimicrobial Resistance (TrACSS) to construct an index of national action, we apply cross-sectional regression across 73 countries to estimate the association between the level of action in 2016 and trends in national indicators (2000-2016). We find that national action is consistently associated with improved linear or categorical trends in all groups of indicators. Reductions are associated with a relatively high action index (range 0-4) for ABU (median 2.8, 25-75% quartile 2.6-3.3), ABR (3.0, 2.4-3.4), and DRI (3.5, 3.1-3.6). These associations are robust to the inclusion of other contextual factors related to socio-economic conditions, human population density, animal production and climate. Since 2016, a majority of both Low- and Middle-Income Countries (LMICs) and High-Income Countries (HICs) report increased action on repeated questions, while one third of countries report reduced action. The main limitations in interpretation are heterogeneity in data availability and in when actions have been implemented. Our findings highlight the importance of national action to address the domestic situation related to antibiotic resistance and indicate the value of both incremental changes in reducing adversity of outcomes and the need for high levels of action in delivering reduced levels of resistance.

国家行动与抗生素耐药性趋势之间的关系:对2000年至2023年73个国家的分析。
世界各国政府已就应对抗生素耐药性挑战的行动达成一致。这就提出了一个问题,即什么程度的国家行动与改善的结果有关,包括减缓增长和降低抗生素耐药性水平。数据可用性和质量的变化以及COVID-19大流行等破坏性事件对回答这个问题提出了挑战。我们调查了与卫生系统能力、抗生素使用(ABU)、绝对耐药性(ABR)和耐药指数(DRI)相关的多个指标的国家行动水平与时间趋势之间的关系。利用全球抗生素耐药性追踪数据库(TrACSS)构建国家行动指数,我们对73个国家进行了横断面回归,以估计2016年行动水平与国家指标趋势(2000-2016年)之间的关联。我们发现,国家行动始终与所有指标组的线性或分类趋势的改善有关。减少与ABU(中位数2.8,25-75%四分位数2.6-3.3)、ABR(3.0, 2.4-3.4)和DRI(3.5, 3.1-3.6)相对较高的作用指数(范围0-4)相关。这些关联在包括与社会经济条件、人口密度、动物生产和气候有关的其他背景因素时是强有力的。自2016年以来,大多数低收入和中等收入国家(LMICs)和高收入国家(HICs)报告称,针对重复问题的行动有所增加,而三分之一的国家报告称,行动有所减少。解释的主要限制是数据可用性和操作实施时间的异质性。我们的研究结果强调了国家行动的重要性,以解决与抗生素耐药性相关的国内情况,并指出了减少结果逆境的增量变化的价值,以及降低耐药性水平的高水平行动的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信